From: Matrix Gla protein (MGP), GATA3, and TRPS1: a novel diagnostic panel to determine breast origin
 | Type | MGP-negative | MGP-positive | Total (n) |
---|---|---|---|---|
Tumors | Breast carcinoma | 126 (10.5) | 1075 (89.5) | 1201 |
Hepatocellular carcinoma | 219 (68.9) | 99 (31.1) | 318 | |
Ovarian carcinoma | 283 (97.6) | 7 (2.4) | 290 | |
Renal cell carcinoma | 114 (94.2) | 6 (5.0) | 121 | |
Lung adenocarcinoma | 295 (99.3) | 2 (0.7) | 297 | |
Urothelial carcinoma | 216 (99.1) | 2 (0.9) | 218 | |
Cholangiocarcinoma | 162 (99.4) | 1 (0.6) | 163 | |
Colorectal adenocarcinoma | 346 (100) | 0 (0) | 346 | |
Gastric adenocarcinoma | 198 (100) | 0 (0) | 198 | |
Thyroid carcinoma | 144 (100) | 0 (0) | 144 | |
Melanoma | 126 (100) | 0 (0) | 126 | |
Normal tissues | Liver (hepatocyte) | 0 (0) | 159 (100) | 159 |
Kidney (renal tubule) | 0 (0) | 61 (100) | 61 | |
Ovary | 121 (100) | 0 (0) | 121 | |
Biliary duct | 159 (100) | 0 (0) | 159 | |
Lung | 212 (100) | 0 (0) | 212 | |
Colorectum | 206 (100) | 0 (0) | 206 | |
Stomach | 137 (100) | 0 (0) | 137 | |
Bladder | 152 (100) | 0 (0) | 152 | |
Thyroid | 144 (100) | 0 (0) | 144 |